Animal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Companion, Others), By Route Of Administration (Subcutaneous, Intramuscular, Intranasal), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others), By Region and Competition, 2019-2029F
Global Animal Vaccine Market was valued at USD 7.68 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.18% through 2029. Vaccines undergo a meticulous and rigorous process of testing and analysis, ensuring their safety and efficacy. This comprehensive testing includes extensive trials that span over several years, evaluating factors such as effectiveness and adoption rates of the newly developed antigen. In the post-trial stage, vaccines play a crucial role in maintaining and controlling the frequency of diseases in animals. This not only safeguards animal health but also has a significant impact on human health, considering the interdependence between humans and animals. The availability and effectiveness of animal vaccines are essential in estimating the public's reliance on animals for various purposes. Among the most commonly used animal vaccines are rabies vaccines, foot mouth disease vaccines, and equine influenza virus vaccines. These vaccines play a pivotal role in preventing the spread of infectious agents by simulating naturally acquired immunity, thus protecting both animal and human populations from potential outbreaks and ensuring overall well-being.
Key Market Drivers
Increasing Pet Adoption Globally
Increasing pet adoption globally has brought about a surge in the demand for animal vaccines, reflecting a growing awareness of responsible pet ownership and the need to safeguard the health of our furry companions. As more people open their homes to animals in need, the risk of disease transmission among pets and from pets to humans has also risen. This necessitates comprehensive vaccination programs to ensure the well-being of these beloved family members.
One of the key drivers behind the increased demand for animal vaccines is the desire to prevent the spread of contagious diseases in crowded shelters and homes. Animal shelters, in particular, house numerous animals in close proximity, making them vulnerable to outbreaks of diseases like parvovirus and kennel cough. Vaccinations provide a vital layer of protection, not only ensuring the health of the shelter's residents but also promoting their chances of finding permanent homes.
Furthermore, as pets become more integrated into our lives, there is a growing understanding of zoonotic diseases—ailments that can be transmitted between animals and humans. This realization has led pet owners to seek vaccination for their animals to mitigate the risk of diseases such as rabies, which can be transmitted from infected pets to humans. Consequently, veterinarians are witnessing an upswing in requests for vaccines to protect both the animals and their human companions. There has been a remarkable increase in animal health awareness among the general public. People are now more informed about the importance of regular veterinary care and preventive measures to ensure the well-being of their pets. This growing awareness has led to a surge in the demand for veterinary medicines, including vaccines, driving the global expansion of the animal vaccines market. In conclusion, the rise in pet ownership, coupled with the recognition of the positive impact that companion animals have on human health, has fueled the growth of the animal vaccines market worldwide. As more families embrace their pets as valued members, the demand for effective vaccines to safeguard their health continues to grow.
Initiatives by Government Agencies, Animal Associations, and Leading Players
The demand for animal vaccines has been steadily rising due to proactive initiatives by government agencies, dedicated animal associations, and leading players in the veterinary and pharmaceutical industries. These collaborative efforts are geared towards improving animal health, mitigating disease outbreaks, and ensuring the safety of both domestic and wild animals. Government agencies play a pivotal role in driving this demand. They often implement vaccination programs to control and prevent the spread of contagious diseases in livestock and wildlife populations. These programs not only protect animal populations but also support food security and public health. For example, government-backed campaigns targeting diseases like foot-and-mouth disease and avian influenza have led to a surge in the need for vaccines in the agricultural sector.
Animal associations, including animal welfare organizations and breed-specific clubs, are also making significant contributions. They educate pet owners and breeders about the importance of vaccination in preventing common diseases among companion animals. These associations often collaborate with veterinarians to offer affordable vaccination clinics, increasing accessibility for pet owners and promoting responsible pet ownership.
Leading players in the veterinary and pharmaceutical industries are continually investing in research and development to innovate and produce more effective and efficient vaccines. Their efforts not only meet the growing demand for vaccines but also drive advancements in animal healthcare, resulting in safer and more reliable products.
Increased Prevalence of Animal Disease
Some of the most prevalent diseases among livestock and companion animals are infectious and contagious illnesses. These diseases pose a significant threat to the health and well-being of animals worldwide. For instance, highly infectious diseases such as canine distemper can easily spread through the air, putting other companion animals at risk. Similarly, conditions like foot-and-mouth disease and contagious bovine pleuropneumonia can have devastating effects on livestock, causing economic losses and impacting food production. Given the high prevalence of these diseases, there is an urgent need for effective vaccines to combat them. Vaccination not only plays a crucial role in protecting the animals but also contributes to the overall financial and physical well-being of both humans and animals. By reducing the incidence and severity of these diseases, vaccines can help ensure a healthier and more sustainable livestock and companion animal industry.
As the awareness of the importance of animal vaccines continues to grow, the demand for them is projected to rise. This increasing demand reflects the recognition of the critical role vaccines play in safeguarding animal health and welfare. By addressing the rise in disease incidence among livestock and companion animals, vaccines can contribute to a safer and more resilient animal population.
Key Market Challenges
Stringent Regulatory Regulations
A drug regulatory authority (DRA) plays a crucial role in ensuring the quality, safety, and efficacy of medicinal products. They oversee the entire lifecycle of these products, from manufacturing and distribution to consumer use. With a focus on maintaining product quality throughout the supply chain, DRAs diligently monitor and certify valid commercial promotions. Their responsibilities include licensing products, inspecting and licensing manufacturers and distributors, conducting post-marketing surveillance, regulating claims made for product promotion, and authorizing clinical trials. Obtaining marketing approval for new vaccines from regulatory agencies is not only a complex process but also a costly and time-consuming endeavor. The ability of companies involved in vaccine development to obtain or maintain these regulatory approvals significantly impacts their financial standing. Hence, navigating the regulatory landscape becomes a critical factor in the success of vaccine development initiatives.
High Storage Costs for Vaccines
The growth of animal vaccine demand faces a significant hindrance in the form of high storage costs. The requirement for proper storage and handling of vaccines is essential to maintain their efficacy and safety. This includes maintaining specific temperature ranges, often referred to as the cold chain, which can be both technologically and financially challenging.
The need for specialized refrigeration equipment and infrastructure increases the cost of vaccine storage. Maintaining a consistent and controlled temperature environment is vital for preserving the potency of vaccines, especially for more delicate ones. This necessity means that veterinary clinics, animal shelters, and agricultural facilities must invest in costly refrigeration systems and backup generators to prevent temperature fluctuations, particularly in areas with unreliable power supplies. The expenses associated with monitoring and quality control measures are substantial. Continuous temperature monitoring, calibration, and regular maintenance of refrigeration units are essential to ensure vaccines remain effective. These ongoing costs can strain the budgets of animal healthcare providers and organizations, discouraging them from maintaining an adequate stock of vaccines.
Key Market Trends
Increase in The Number Of RD Activities
An increase in research and development activities aimed at designing effective, efficient, and high-quality vaccines for companion animals, such as dogs and cats, as well as farm animals, including horses, cows, and pigs, is expected to create promising opportunities for the veterinary-animal vaccines market. The launch of new products with improved efficacy and safety profiles will further contribute to the growth of this market. Moreover, significant technological advancements in the development of animal health vaccines, such as the use of novel adjuvants and delivery systems, are anticipated to drive the expansion of the veterinary-animal vaccines market during the forecast period. These advancements will enable the development of vaccines that provide superior protection against infectious diseases and promote better overall animal health.
Additionally, the increasing number of emerging markets, particularly in developing countries, presents a favorable environment for the growth of the veterinary-animal vaccines market. The rising awareness about the importance of animal health, coupled with the growing investments in veterinary infrastructure, will contribute to the increased adoption of vaccines for livestock and companion animals. Furthermore, the growing population of cattle and poultry in developing countries, along with the advancements in healthcare technology, including diagnostics and preventive care, will further accelerate the growth rate of the veterinary-animal vaccines market in the future. This is driven by the need to ensure the health and well-being of animals, which in turn has a direct impact on food security and public health. In conclusion, the veterinary-animal vaccines market is poised for significant growth due to the increasing focus on animal health, technological advancements, expanding markets, and the need for sustainable and safe food production.
Increase in Livestock Production
In livestock farming, veterinary vaccinations play a crucial role in enhancing overall productivity and ensuring the well-being of animals. Given the increasing global population, it is imperative to improve livestock production efficiency and enhance access to high-quality protein in order to meet the growing demand for food. According to the FAO High-Level Expert Forum, a projected global population of 9.1 billion people by 2050 necessitates a 70% increase in overall food production from 2005 levels. Vaccinations that safeguard animal health and bolster the supply chain are indispensable in achieving this objective. Moreover, they help reduce the reliance on antimicrobials for treating infections in both food-producing and companion animals. This is particularly important due to mounting concerns about antibiotic resistance in human and veterinary medicine, as well as the capacity of vaccinations to mitigate the proliferation of organisms that cause foodborne illnesses in humans. These factors contribute significantly to the growth potential of the market in the forecast period.
Segmental Insights
Product Insights
Based on the product, the segment of attenuated live vaccines has emerged as the dominant force in the animal vaccine market, accounting for a significant revenue share in 2023. Live attenuation stands as the oldest vaccination method employed in veterinary medicine, with ongoing trials exploring its potential for additional applications. Notably, this method is being evaluated for the development of protein subunit vaccines for swine, administered intramuscularly. These products play a pivotal role in reducing swine mortality rates and enhancing their overall lifespan amidst disease outbreaks. On the other hand, the recombinant vaccine segment exhibits remarkable growth potential throughout the forecast period. These vaccines effectively mitigate the risk of pathogenicity in animals’ post-vaccination. Moreover, recombinant vaccines possess the capability to provide immunization against multiple virus strains, as they can accommodate multiple gene inserts. This unique attribute eliminates the need for adjuvants, enhances vaccine viability, and improves overall stability. Within the realm of veterinary medicine, notable recombinant vaccines include those targeting canine distemper, pseudorabies, Newcastle disease, Lyme disease, and avian influenza.
Animal Type Insights
Based on the animal type, the livestock segment emerged as the dominant force in the market, capturing the highest revenue share. This can be attributed to several factors, including the significant increase in the livestock population, the implementation of supportive government initiatives, and the unfortunate outbreak of diseases among cattle and sheep. Looking ahead, the companion segment is poised to exhibit the fastest growth rate during the forecast period. As pet ownership continues to rise and the demand for animal companionship grows, this segment is expected to flourish, presenting lucrative opportunities for market players.
Regional Insights
North America, comprising the United States and Canada, is estimated to hold the largest market share in the canine disorders industry. The increasing incidence of canine disorders, including but not limited to allergies, respiratory issues, and gastrointestinal problems, has led to a higher adoption of vaccination and preventive measures in the region. This, coupled with the rising pet population and the presence of ongoing research projects and initiatives, is expected to further boost the market in North America. The region's commitment to pet healthcare and continuous advancements in research and development contribute to its dominant position in the market. Efforts are being made to understand the root causes of various canine disorders and develop innovative treatments and therapies to improve the overall well-being of our beloved furry companions. The collaborative efforts of veterinarians, scientists, and pet owners in North America pave the way for advancements in the field of veterinary medicine, ensuring the best possible care for our four-legged friends.
Key Market Players
Zoetis Inc.
Merck Co., Inc.
Boehringer Ingelheim International GmbH
Biogenesis Bago SA
Indian Immunologicals Ltd.
Elanco Animal Health Incorporated
Phibro Animal Health Corporation
Neogen Corporation
Intas Pharmaceuticals Ltd.
Ouro Fino Saude Animal
Report Scope:
In this report, the Global Animal Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Animal Vaccine Market,By Product:
oAttenuated Live Vaccines
oInactivated Vaccines
oSubunit Vaccines
oDNA Vaccines
oRecombinant Vaccines
Animal Vaccine Market,By Animal Type:
oLivestock
oCompanion
oOthers
Animal Vaccine Market,By Route of Administration:
oSubcutaneous
oIntramuscular
oIntranasal
Animal Vaccine Market,By Distribution Channel:
oVeterinary Hospitals
oVeterinary Clinics
oPharmacies Drug Stores
oOthers
Animal Vaccine Market, By Region:
oNorth America
Company Profiles: Detailed analysis of the major companies present in the Global Animal Vaccine Market.
Available Customizations:
Global Animal Vaccine marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Key Market Drivers
Increasing Pet Adoption Globally
Increasing pet adoption globally has brought about a surge in the demand for animal vaccines, reflecting a growing awareness of responsible pet ownership and the need to safeguard the health of our furry companions. As more people open their homes to animals in need, the risk of disease transmission among pets and from pets to humans has also risen. This necessitates comprehensive vaccination programs to ensure the well-being of these beloved family members.
One of the key drivers behind the increased demand for animal vaccines is the desire to prevent the spread of contagious diseases in crowded shelters and homes. Animal shelters, in particular, house numerous animals in close proximity, making them vulnerable to outbreaks of diseases like parvovirus and kennel cough. Vaccinations provide a vital layer of protection, not only ensuring the health of the shelter's residents but also promoting their chances of finding permanent homes.
Furthermore, as pets become more integrated into our lives, there is a growing understanding of zoonotic diseases—ailments that can be transmitted between animals and humans. This realization has led pet owners to seek vaccination for their animals to mitigate the risk of diseases such as rabies, which can be transmitted from infected pets to humans. Consequently, veterinarians are witnessing an upswing in requests for vaccines to protect both the animals and their human companions. There has been a remarkable increase in animal health awareness among the general public. People are now more informed about the importance of regular veterinary care and preventive measures to ensure the well-being of their pets. This growing awareness has led to a surge in the demand for veterinary medicines, including vaccines, driving the global expansion of the animal vaccines market. In conclusion, the rise in pet ownership, coupled with the recognition of the positive impact that companion animals have on human health, has fueled the growth of the animal vaccines market worldwide. As more families embrace their pets as valued members, the demand for effective vaccines to safeguard their health continues to grow.
Initiatives by Government Agencies, Animal Associations, and Leading Players
The demand for animal vaccines has been steadily rising due to proactive initiatives by government agencies, dedicated animal associations, and leading players in the veterinary and pharmaceutical industries. These collaborative efforts are geared towards improving animal health, mitigating disease outbreaks, and ensuring the safety of both domestic and wild animals. Government agencies play a pivotal role in driving this demand. They often implement vaccination programs to control and prevent the spread of contagious diseases in livestock and wildlife populations. These programs not only protect animal populations but also support food security and public health. For example, government-backed campaigns targeting diseases like foot-and-mouth disease and avian influenza have led to a surge in the need for vaccines in the agricultural sector.
Animal associations, including animal welfare organizations and breed-specific clubs, are also making significant contributions. They educate pet owners and breeders about the importance of vaccination in preventing common diseases among companion animals. These associations often collaborate with veterinarians to offer affordable vaccination clinics, increasing accessibility for pet owners and promoting responsible pet ownership.
Leading players in the veterinary and pharmaceutical industries are continually investing in research and development to innovate and produce more effective and efficient vaccines. Their efforts not only meet the growing demand for vaccines but also drive advancements in animal healthcare, resulting in safer and more reliable products.
Increased Prevalence of Animal Disease
Some of the most prevalent diseases among livestock and companion animals are infectious and contagious illnesses. These diseases pose a significant threat to the health and well-being of animals worldwide. For instance, highly infectious diseases such as canine distemper can easily spread through the air, putting other companion animals at risk. Similarly, conditions like foot-and-mouth disease and contagious bovine pleuropneumonia can have devastating effects on livestock, causing economic losses and impacting food production. Given the high prevalence of these diseases, there is an urgent need for effective vaccines to combat them. Vaccination not only plays a crucial role in protecting the animals but also contributes to the overall financial and physical well-being of both humans and animals. By reducing the incidence and severity of these diseases, vaccines can help ensure a healthier and more sustainable livestock and companion animal industry.
As the awareness of the importance of animal vaccines continues to grow, the demand for them is projected to rise. This increasing demand reflects the recognition of the critical role vaccines play in safeguarding animal health and welfare. By addressing the rise in disease incidence among livestock and companion animals, vaccines can contribute to a safer and more resilient animal population.
Key Market Challenges
Stringent Regulatory Regulations
A drug regulatory authority (DRA) plays a crucial role in ensuring the quality, safety, and efficacy of medicinal products. They oversee the entire lifecycle of these products, from manufacturing and distribution to consumer use. With a focus on maintaining product quality throughout the supply chain, DRAs diligently monitor and certify valid commercial promotions. Their responsibilities include licensing products, inspecting and licensing manufacturers and distributors, conducting post-marketing surveillance, regulating claims made for product promotion, and authorizing clinical trials. Obtaining marketing approval for new vaccines from regulatory agencies is not only a complex process but also a costly and time-consuming endeavor. The ability of companies involved in vaccine development to obtain or maintain these regulatory approvals significantly impacts their financial standing. Hence, navigating the regulatory landscape becomes a critical factor in the success of vaccine development initiatives.
High Storage Costs for Vaccines
The growth of animal vaccine demand faces a significant hindrance in the form of high storage costs. The requirement for proper storage and handling of vaccines is essential to maintain their efficacy and safety. This includes maintaining specific temperature ranges, often referred to as the cold chain, which can be both technologically and financially challenging.
The need for specialized refrigeration equipment and infrastructure increases the cost of vaccine storage. Maintaining a consistent and controlled temperature environment is vital for preserving the potency of vaccines, especially for more delicate ones. This necessity means that veterinary clinics, animal shelters, and agricultural facilities must invest in costly refrigeration systems and backup generators to prevent temperature fluctuations, particularly in areas with unreliable power supplies. The expenses associated with monitoring and quality control measures are substantial. Continuous temperature monitoring, calibration, and regular maintenance of refrigeration units are essential to ensure vaccines remain effective. These ongoing costs can strain the budgets of animal healthcare providers and organizations, discouraging them from maintaining an adequate stock of vaccines.
Key Market Trends
Increase in The Number Of RD Activities
An increase in research and development activities aimed at designing effective, efficient, and high-quality vaccines for companion animals, such as dogs and cats, as well as farm animals, including horses, cows, and pigs, is expected to create promising opportunities for the veterinary-animal vaccines market. The launch of new products with improved efficacy and safety profiles will further contribute to the growth of this market. Moreover, significant technological advancements in the development of animal health vaccines, such as the use of novel adjuvants and delivery systems, are anticipated to drive the expansion of the veterinary-animal vaccines market during the forecast period. These advancements will enable the development of vaccines that provide superior protection against infectious diseases and promote better overall animal health.
Additionally, the increasing number of emerging markets, particularly in developing countries, presents a favorable environment for the growth of the veterinary-animal vaccines market. The rising awareness about the importance of animal health, coupled with the growing investments in veterinary infrastructure, will contribute to the increased adoption of vaccines for livestock and companion animals. Furthermore, the growing population of cattle and poultry in developing countries, along with the advancements in healthcare technology, including diagnostics and preventive care, will further accelerate the growth rate of the veterinary-animal vaccines market in the future. This is driven by the need to ensure the health and well-being of animals, which in turn has a direct impact on food security and public health. In conclusion, the veterinary-animal vaccines market is poised for significant growth due to the increasing focus on animal health, technological advancements, expanding markets, and the need for sustainable and safe food production.
Increase in Livestock Production
In livestock farming, veterinary vaccinations play a crucial role in enhancing overall productivity and ensuring the well-being of animals. Given the increasing global population, it is imperative to improve livestock production efficiency and enhance access to high-quality protein in order to meet the growing demand for food. According to the FAO High-Level Expert Forum, a projected global population of 9.1 billion people by 2050 necessitates a 70% increase in overall food production from 2005 levels. Vaccinations that safeguard animal health and bolster the supply chain are indispensable in achieving this objective. Moreover, they help reduce the reliance on antimicrobials for treating infections in both food-producing and companion animals. This is particularly important due to mounting concerns about antibiotic resistance in human and veterinary medicine, as well as the capacity of vaccinations to mitigate the proliferation of organisms that cause foodborne illnesses in humans. These factors contribute significantly to the growth potential of the market in the forecast period.
Segmental Insights
Product Insights
Based on the product, the segment of attenuated live vaccines has emerged as the dominant force in the animal vaccine market, accounting for a significant revenue share in 2023. Live attenuation stands as the oldest vaccination method employed in veterinary medicine, with ongoing trials exploring its potential for additional applications. Notably, this method is being evaluated for the development of protein subunit vaccines for swine, administered intramuscularly. These products play a pivotal role in reducing swine mortality rates and enhancing their overall lifespan amidst disease outbreaks. On the other hand, the recombinant vaccine segment exhibits remarkable growth potential throughout the forecast period. These vaccines effectively mitigate the risk of pathogenicity in animals’ post-vaccination. Moreover, recombinant vaccines possess the capability to provide immunization against multiple virus strains, as they can accommodate multiple gene inserts. This unique attribute eliminates the need for adjuvants, enhances vaccine viability, and improves overall stability. Within the realm of veterinary medicine, notable recombinant vaccines include those targeting canine distemper, pseudorabies, Newcastle disease, Lyme disease, and avian influenza.
Animal Type Insights
Based on the animal type, the livestock segment emerged as the dominant force in the market, capturing the highest revenue share. This can be attributed to several factors, including the significant increase in the livestock population, the implementation of supportive government initiatives, and the unfortunate outbreak of diseases among cattle and sheep. Looking ahead, the companion segment is poised to exhibit the fastest growth rate during the forecast period. As pet ownership continues to rise and the demand for animal companionship grows, this segment is expected to flourish, presenting lucrative opportunities for market players.
Regional Insights
North America, comprising the United States and Canada, is estimated to hold the largest market share in the canine disorders industry. The increasing incidence of canine disorders, including but not limited to allergies, respiratory issues, and gastrointestinal problems, has led to a higher adoption of vaccination and preventive measures in the region. This, coupled with the rising pet population and the presence of ongoing research projects and initiatives, is expected to further boost the market in North America. The region's commitment to pet healthcare and continuous advancements in research and development contribute to its dominant position in the market. Efforts are being made to understand the root causes of various canine disorders and develop innovative treatments and therapies to improve the overall well-being of our beloved furry companions. The collaborative efforts of veterinarians, scientists, and pet owners in North America pave the way for advancements in the field of veterinary medicine, ensuring the best possible care for our four-legged friends.
Key Market Players
Zoetis Inc.
Merck Co., Inc.
Boehringer Ingelheim International GmbH
Biogenesis Bago SA
Indian Immunologicals Ltd.
Elanco Animal Health Incorporated
Phibro Animal Health Corporation
Neogen Corporation
Intas Pharmaceuticals Ltd.
Ouro Fino Saude Animal
Report Scope:
In this report, the Global Animal Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Animal Vaccine Market,By Product:
oAttenuated Live Vaccines
oInactivated Vaccines
oSubunit Vaccines
oDNA Vaccines
oRecombinant Vaccines
Animal Vaccine Market,By Animal Type:
oLivestock
oCompanion
oOthers
Animal Vaccine Market,By Route of Administration:
oSubcutaneous
oIntramuscular
oIntranasal
Animal Vaccine Market,By Distribution Channel:
oVeterinary Hospitals
oVeterinary Clinics
oPharmacies Drug Stores
oOthers
Animal Vaccine Market, By Region:
oNorth America
- United States
- Canada
- Mexico
- France
- United Kingdom
- Italy
- Germany
- Spain
- China
- India
- Japan
- Australia
- South Korea
- Brazil
- Argentina
- Colombia
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Animal Vaccine Market.
Available Customizations:
Global Animal Vaccine marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
1.PRODUCT OVERVIEW
1.1.Market Definition
1.2.Scope of the Market
1.2.1.Markets Covered
1.2.2.Years Considered for Study
1.2.3.Key Market Segmentations
2.RESEARCH METHODOLOGY
2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation Validations
2.7.Assumptions and Limitations
3.EXECUTIVE SUMMARY
3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends
4.VOICE OF CUSTOMER
5.GLOBAL ANIMAL VACCINE MARKET OUTLOOK
5.1.Market Size Forecast
5.1.1.By Value
5.2.Market Share Forecast
5.2.1.By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
5.2.2.By Animal Type (Livestock, Companion, Others)
5.2.3.By Route Of Administration (Subcutaneous, Intramuscular, Intranasal)
5.2.4.By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies Drug Stores, Others)
5.2.5.By Region
5.2.6.By Company (2023)
5.3.Market Map
6.NORTH AMERICA ANIMAL VACCINE MARKET OUTLOOK
6.1.Market Size Forecast
6.1.1.By Value
6.2.Market Share Forecast
6.2.1.ByProduct
6.2.2.By Animal Type
6.2.3.By Route Of Administration
6.2.4.By Distribution Channel
6.2.5.By Country
6.3.North America: Country Analysis
6.3.1.United States Animal Vaccine Market Outlook
6.3.1.1.Market Size Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share Forecast
6.3.1.2.1.By Product
6.3.1.2.2.By Animal Type
6.3.1.2.3.By Route Of Administration
6.3.1.2.4.By Distribution Channel
6.3.2.Canada Animal Vaccine Market Outlook
6.3.2.1.Market Size Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share Forecast
6.3.2.2.1.By Product
6.3.2.2.2.By Animal Type
6.3.2.2.3.By Route Of Administration
6.3.2.2.4.By Distribution Channel
6.3.3.Mexico Animal Vaccine Market Outlook
6.3.3.1.Market Size Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share Forecast
6.3.3.2.1.By Product
6.3.3.2.2.By Animal Type
6.3.3.2.3.By Route Of Administration
6.3.3.2.4.By Distribution Channel
7.EUROPE ANIMAL VACCINE MARKET OUTLOOK
7.1.Market Size Forecast
7.1.1.By Value
7.2.Market Share Forecast
7.2.1.By Product
7.2.2.By Animal Type
7.2.3.By Route Of Administration
7.2.4.By Distribution Channel
7.2.5.By Country
7.3.Europe: Country Analysis
7.3.1.Germany Animal Vaccine Market Outlook
7.3.1.1.Market Size Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share Forecast
7.3.1.2.1.By Product
7.3.1.2.2.By Animal Type
7.3.1.2.3.By Route Of Administration
7.3.1.2.4.By Distribution Channel
7.3.2.United Kingdom Animal Vaccine Market Outlook
7.3.2.1.Market Size Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share Forecast
7.3.2.2.1.By Product
7.3.2.2.2.By Animal Type
7.3.2.2.3.By Route Of Administration
7.3.2.2.4.By Distribution Channel
7.3.3.Italy Animal Vaccine Market Outlook
7.3.3.1.Market Size Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share Forecasty
7.3.3.2.1.By Product
7.3.3.2.2.By Animal Type
7.3.3.2.3.By Route Of Administration
7.3.3.2.4.By Distribution Channel
7.3.4.France Animal Vaccine Market Outlook
7.3.4.1.Market Size Forecast
7.3.4.1.1.By Value
7.3.4.2.Market Share Forecast
7.3.4.2.1.By Product
7.3.4.2.2.By Animal Type
7.3.4.2.3.By Route Of Administration
7.3.4.2.4.By Distribution Channel
7.3.5.Spain Animal Vaccine Market Outlook
7.3.5.1.Market Size Forecast
7.3.5.1.1.By Value
7.3.5.2.Market Share Forecast
7.3.5.2.1.By Product
7.3.5.2.2.By Animal Type
7.3.5.2.3.By Route Of Administration
7.3.5.2.4.By Distribution Channel
8.ASIA-PACIFIC ANIMAL VACCINE MARKET OUTLOOK
8.1.Market Size Forecast
8.1.1.By Value
8.2.Market Share Forecast
8.2.1.By Product
8.2.2.By Animal Type
8.2.3.By Route Of Administration
8.2.4.By Distribution Channel
8.2.5.By Country
8.3.Asia-Pacific: Country Analysis
8.3.1.China Animal Vaccine Market Outlook
8.3.1.1.Market Size Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share Forecast
8.3.1.2.1.By Product
8.3.1.2.2.By Animal Type
8.3.1.2.3.By Route Of Administration
8.3.1.2.4.By Distribution Channel
8.3.2.India Animal Vaccine Market Outlook
8.3.2.1.Market Size Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share Forecast
8.3.2.2.1.By Product
8.3.2.2.2.By Animal Type
8.3.2.2.3.By Route Of Administration
8.3.2.2.4.By Distribution Channel
8.3.3.Japan Animal Vaccine Market Outlook
8.3.3.1.Market Size Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share Forecast
8.3.3.2.1.By Product
8.3.3.2.2.By Animal Type
8.3.3.2.3.By Route Of Administration
8.3.3.2.4.By Distribution Channel
8.3.4.South Korea Animal Vaccine Market Outlook
8.3.4.1.Market Size Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share Forecast
8.3.4.2.1.By Product
8.3.4.2.2.By Animal Type
8.3.4.2.3.By Route Of Administration
8.3.4.2.4.By Distribution Channel
8.3.5.Australia Animal Vaccine Market Outlook
8.3.5.1.Market Size Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share Forecast
8.3.5.2.1.By Product
8.3.5.2.2.By Animal Type
8.3.5.2.3.By Route Of Administration
8.3.5.2.4.By Distribution Channel
9.SOUTH AMERICA ANIMAL VACCINE MARKET OUTLOOK
9.1.Market Size Forecast
9.1.1.By Value
9.2.Market Share Forecast
9.2.1.By Product
9.2.2.By Animal Type
9.2.3.By Route Of Administration
9.2.4.By Distribution Channel
9.2.5.By Country
9.3.South America: Country Analysis
9.3.1.Brazil Animal Vaccine Market Outlook
9.3.1.1.Market Size Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share Forecast
9.3.1.2.1.By Product
9.3.1.2.2.By Animal Type
9.3.1.2.3.By Route Of Administration
9.3.1.2.4.By Distribution Channel
9.3.2.Argentina Animal Vaccine Market Outlook
9.3.2.1.Market Size Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share Forecast
9.3.2.2.1.By Product
9.3.2.2.2.By Animal Type
9.3.2.2.3.By Route Of Administration
9.3.2.2.4.By Distribution Channel
9.3.3.Colombia Animal Vaccine Market Outlook
9.3.3.1.Market Size Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share Forecast
9.3.3.2.1.By Product
9.3.3.2.2.By Animal Type
9.3.3.2.3.By Route Of Administration
9.3.3.2.4.By Distribution Channel
10.MIDDLE EAST AND AFRICA ANIMAL VACCINE MARKET OUTLOOK
10.1.Market Size Forecast
10.1.1.By Value
10.2.Market Share Forecast
10.2.1.By Product
10.2.2.By Animal Type
10.2.3.By Route Of Administration
10.2.4.By Distribution Channel
10.2.5.By Country
10.3.MEA: Country Analysis
10.3.1.South Africa Animal Vaccine Market Outlook
10.3.1.1.Market Size Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share Forecast
10.3.1.2.1.By Product
10.3.1.2.2.By Animal Type
10.3.1.2.3.By Route Of Administration
10.3.1.2.4.By Distribution Channel
10.3.2.Saudi Arabia Animal Vaccine Market Outlook
10.3.2.1.Market Size Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share Forecast
10.3.2.2.1.By Product
10.3.2.2.2.By Animal Type
10.3.2.2.3.By Route Of Administration
10.3.2.2.4.By Distribution Channel
10.3.3.UAE Animal Vaccine Market Outlook
10.3.3.1.Market Size Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share Forecast
10.3.3.2.1.By Product
10.3.3.2.2.By Animal Type
10.3.3.2.3.By Route Of Administration
10.3.3.2.4.By Distribution Channel
11.MARKET DYNAMICS
11.1.Drivers
11.2.Challenges
12.MARKET TRENDS DEVELOPMENTS
12.1.Merger Acquisition (If Any)
12.2.Product Launches (If Any)
12.3.Recent Developments
13.PORTERS FIVE FORCES ANALYSIS
13.1.Competition in the Industry
13.2.Potential of New Entrants
13.3.Power of Suppliers
13.4.Power of Customers
13.5.Threat of Substitute Products
14.COMPETITIVE LANDSCAPE
14.1.Zoetis Inc.
14.1.1.Business Overview
14.1.2.Company Snapshot
14.1.3.Products Services
14.1.4.Financials (As Reported)
14.1.5.Recent Developments
14.1.6.Key Personnel Details
14.1.7.SWOT Analysis
14.2.Merck Co., Inc.
14.3.Boehringer Ingelheim International GmbH
14.4.Biogenesis Bago SA
14.5.Indian Immunologicals Ltd.
14.6.ElancoAnimal Health Incorporated
14.7.Phibro Animal Health Corporation
14.8.Neogen Corporation
14.9.Intas Pharmaceuticals Ltd.
14.10.Ouro Fino Saude Animal
15.STRATEGIC RECOMMENDATIONS
16.ABOUT US DISCLAIMER
1.1.Market Definition
1.2.Scope of the Market
1.2.1.Markets Covered
1.2.2.Years Considered for Study
1.2.3.Key Market Segmentations
2.RESEARCH METHODOLOGY
2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation Validations
2.7.Assumptions and Limitations
3.EXECUTIVE SUMMARY
3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends
4.VOICE OF CUSTOMER
5.GLOBAL ANIMAL VACCINE MARKET OUTLOOK
5.1.Market Size Forecast
5.1.1.By Value
5.2.Market Share Forecast
5.2.1.By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
5.2.2.By Animal Type (Livestock, Companion, Others)
5.2.3.By Route Of Administration (Subcutaneous, Intramuscular, Intranasal)
5.2.4.By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies Drug Stores, Others)
5.2.5.By Region
5.2.6.By Company (2023)
5.3.Market Map
6.NORTH AMERICA ANIMAL VACCINE MARKET OUTLOOK
6.1.Market Size Forecast
6.1.1.By Value
6.2.Market Share Forecast
6.2.1.ByProduct
6.2.2.By Animal Type
6.2.3.By Route Of Administration
6.2.4.By Distribution Channel
6.2.5.By Country
6.3.North America: Country Analysis
6.3.1.United States Animal Vaccine Market Outlook
6.3.1.1.Market Size Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share Forecast
6.3.1.2.1.By Product
6.3.1.2.2.By Animal Type
6.3.1.2.3.By Route Of Administration
6.3.1.2.4.By Distribution Channel
6.3.2.Canada Animal Vaccine Market Outlook
6.3.2.1.Market Size Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share Forecast
6.3.2.2.1.By Product
6.3.2.2.2.By Animal Type
6.3.2.2.3.By Route Of Administration
6.3.2.2.4.By Distribution Channel
6.3.3.Mexico Animal Vaccine Market Outlook
6.3.3.1.Market Size Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share Forecast
6.3.3.2.1.By Product
6.3.3.2.2.By Animal Type
6.3.3.2.3.By Route Of Administration
6.3.3.2.4.By Distribution Channel
7.EUROPE ANIMAL VACCINE MARKET OUTLOOK
7.1.Market Size Forecast
7.1.1.By Value
7.2.Market Share Forecast
7.2.1.By Product
7.2.2.By Animal Type
7.2.3.By Route Of Administration
7.2.4.By Distribution Channel
7.2.5.By Country
7.3.Europe: Country Analysis
7.3.1.Germany Animal Vaccine Market Outlook
7.3.1.1.Market Size Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share Forecast
7.3.1.2.1.By Product
7.3.1.2.2.By Animal Type
7.3.1.2.3.By Route Of Administration
7.3.1.2.4.By Distribution Channel
7.3.2.United Kingdom Animal Vaccine Market Outlook
7.3.2.1.Market Size Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share Forecast
7.3.2.2.1.By Product
7.3.2.2.2.By Animal Type
7.3.2.2.3.By Route Of Administration
7.3.2.2.4.By Distribution Channel
7.3.3.Italy Animal Vaccine Market Outlook
7.3.3.1.Market Size Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share Forecasty
7.3.3.2.1.By Product
7.3.3.2.2.By Animal Type
7.3.3.2.3.By Route Of Administration
7.3.3.2.4.By Distribution Channel
7.3.4.France Animal Vaccine Market Outlook
7.3.4.1.Market Size Forecast
7.3.4.1.1.By Value
7.3.4.2.Market Share Forecast
7.3.4.2.1.By Product
7.3.4.2.2.By Animal Type
7.3.4.2.3.By Route Of Administration
7.3.4.2.4.By Distribution Channel
7.3.5.Spain Animal Vaccine Market Outlook
7.3.5.1.Market Size Forecast
7.3.5.1.1.By Value
7.3.5.2.Market Share Forecast
7.3.5.2.1.By Product
7.3.5.2.2.By Animal Type
7.3.5.2.3.By Route Of Administration
7.3.5.2.4.By Distribution Channel
8.ASIA-PACIFIC ANIMAL VACCINE MARKET OUTLOOK
8.1.Market Size Forecast
8.1.1.By Value
8.2.Market Share Forecast
8.2.1.By Product
8.2.2.By Animal Type
8.2.3.By Route Of Administration
8.2.4.By Distribution Channel
8.2.5.By Country
8.3.Asia-Pacific: Country Analysis
8.3.1.China Animal Vaccine Market Outlook
8.3.1.1.Market Size Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share Forecast
8.3.1.2.1.By Product
8.3.1.2.2.By Animal Type
8.3.1.2.3.By Route Of Administration
8.3.1.2.4.By Distribution Channel
8.3.2.India Animal Vaccine Market Outlook
8.3.2.1.Market Size Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share Forecast
8.3.2.2.1.By Product
8.3.2.2.2.By Animal Type
8.3.2.2.3.By Route Of Administration
8.3.2.2.4.By Distribution Channel
8.3.3.Japan Animal Vaccine Market Outlook
8.3.3.1.Market Size Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share Forecast
8.3.3.2.1.By Product
8.3.3.2.2.By Animal Type
8.3.3.2.3.By Route Of Administration
8.3.3.2.4.By Distribution Channel
8.3.4.South Korea Animal Vaccine Market Outlook
8.3.4.1.Market Size Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share Forecast
8.3.4.2.1.By Product
8.3.4.2.2.By Animal Type
8.3.4.2.3.By Route Of Administration
8.3.4.2.4.By Distribution Channel
8.3.5.Australia Animal Vaccine Market Outlook
8.3.5.1.Market Size Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share Forecast
8.3.5.2.1.By Product
8.3.5.2.2.By Animal Type
8.3.5.2.3.By Route Of Administration
8.3.5.2.4.By Distribution Channel
9.SOUTH AMERICA ANIMAL VACCINE MARKET OUTLOOK
9.1.Market Size Forecast
9.1.1.By Value
9.2.Market Share Forecast
9.2.1.By Product
9.2.2.By Animal Type
9.2.3.By Route Of Administration
9.2.4.By Distribution Channel
9.2.5.By Country
9.3.South America: Country Analysis
9.3.1.Brazil Animal Vaccine Market Outlook
9.3.1.1.Market Size Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share Forecast
9.3.1.2.1.By Product
9.3.1.2.2.By Animal Type
9.3.1.2.3.By Route Of Administration
9.3.1.2.4.By Distribution Channel
9.3.2.Argentina Animal Vaccine Market Outlook
9.3.2.1.Market Size Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share Forecast
9.3.2.2.1.By Product
9.3.2.2.2.By Animal Type
9.3.2.2.3.By Route Of Administration
9.3.2.2.4.By Distribution Channel
9.3.3.Colombia Animal Vaccine Market Outlook
9.3.3.1.Market Size Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share Forecast
9.3.3.2.1.By Product
9.3.3.2.2.By Animal Type
9.3.3.2.3.By Route Of Administration
9.3.3.2.4.By Distribution Channel
10.MIDDLE EAST AND AFRICA ANIMAL VACCINE MARKET OUTLOOK
10.1.Market Size Forecast
10.1.1.By Value
10.2.Market Share Forecast
10.2.1.By Product
10.2.2.By Animal Type
10.2.3.By Route Of Administration
10.2.4.By Distribution Channel
10.2.5.By Country
10.3.MEA: Country Analysis
10.3.1.South Africa Animal Vaccine Market Outlook
10.3.1.1.Market Size Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share Forecast
10.3.1.2.1.By Product
10.3.1.2.2.By Animal Type
10.3.1.2.3.By Route Of Administration
10.3.1.2.4.By Distribution Channel
10.3.2.Saudi Arabia Animal Vaccine Market Outlook
10.3.2.1.Market Size Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share Forecast
10.3.2.2.1.By Product
10.3.2.2.2.By Animal Type
10.3.2.2.3.By Route Of Administration
10.3.2.2.4.By Distribution Channel
10.3.3.UAE Animal Vaccine Market Outlook
10.3.3.1.Market Size Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share Forecast
10.3.3.2.1.By Product
10.3.3.2.2.By Animal Type
10.3.3.2.3.By Route Of Administration
10.3.3.2.4.By Distribution Channel
11.MARKET DYNAMICS
11.1.Drivers
11.2.Challenges
12.MARKET TRENDS DEVELOPMENTS
12.1.Merger Acquisition (If Any)
12.2.Product Launches (If Any)
12.3.Recent Developments
13.PORTERS FIVE FORCES ANALYSIS
13.1.Competition in the Industry
13.2.Potential of New Entrants
13.3.Power of Suppliers
13.4.Power of Customers
13.5.Threat of Substitute Products
14.COMPETITIVE LANDSCAPE
14.1.Zoetis Inc.
14.1.1.Business Overview
14.1.2.Company Snapshot
14.1.3.Products Services
14.1.4.Financials (As Reported)
14.1.5.Recent Developments
14.1.6.Key Personnel Details
14.1.7.SWOT Analysis
14.2.Merck Co., Inc.
14.3.Boehringer Ingelheim International GmbH
14.4.Biogenesis Bago SA
14.5.Indian Immunologicals Ltd.
14.6.ElancoAnimal Health Incorporated
14.7.Phibro Animal Health Corporation
14.8.Neogen Corporation
14.9.Intas Pharmaceuticals Ltd.
14.10.Ouro Fino Saude Animal
15.STRATEGIC RECOMMENDATIONS
16.ABOUT US DISCLAIMER
